Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Geron Corporation (GERN)
(
)
Quote & Articles
Transcripts
Instablogs
StockTalks
Comments on articles
Cramer
Authors on GERN
Newest on GERN
Beacon Asset Managers
(2)
M. E. Garza
(1)
The Burrill Report
(1)
VFC's Stock House
(1)
Ryan Pollack
(1)
Most frequent on GERN
Mike Havrilla
(
8
)
Alan Brochstein
(
6
)
Centient Biotech Investor
(
5
)
SA Editor Miriam Metzinger
(
5
)
Frederic Ruffy
(
5
)
Most followed on GERN
SA Editor Rachael Granby
(
1326
)
Mike Havrilla
(
1130
)
Andrew Wilkinson
(
871
)
Andrew Mickey
(
835
)
Bill Cara
(
703
)
Most commented on GERN
Andrew Mickey
(
45
)
SA Editor Rachael Granby
(
38
)
Mike Havrilla
(
23
)
Eric Falkenstein
(
18
)
Kelvin Schulle
(
17
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on Geron Corporation (GERN)
by
latest
|
most commented
3 Briefs to Open the Week
Jul 7
•
VFC's Stock House
•
CSUH.OB
,
SIRI
,
GERN
•
1 Comment
|
Quick Read
Monday's Closing Update
Jul 6
•
MidnightTrader.com
•
AA
,
AXP
,
BT
•
5 Comments
|
Quick Read
Dealmaking Sweeps the Biotech Sector
Jul 5
•
The Burrill Report
•
BIIB
,
BPA
,
ACOR
•
Comment!
|
Quick Read
Geron Pushes Higher on GE Healthcare Alliance
Jul 1
•
Beacon Asset Managers
•
GERN
,
GE
•
Comment!
|
Quick Read
Closing Update for Tuesday June 30
Jun 30
•
MidnightTrader.com
•
ASTM
,
APOL
,
ABT
•
Comment!
|
Quick Read
Tuesday Options Update: ELX, GERN, VALE, NVDA & EXC
Jun 30
•
Andrew Wilkinson
•
EXC
,
ELX
,
GERN
•
Comment!
|
Quick Read
Adult Stem Cell Drugs and Therapies Are the Next Big Market
Jun 18
•
M. E. Garza
•
GENZ
,
CYTX
,
ASTM
•
9 Comments
|
Quick Read
Geron's Risk-Reward Profile - Best in Biotech?
Jun 12
•
Beacon Asset Managers
•
GERN
•
12 Comments
|
Quick Read
Geron: Strong Investment in Human Embryonic Stem Cell Research
May 25
•
Ryan Pollack
•
GERN
•
15 Comments
|
Quick Read
Thursday's Options Recap
May 21
•
Frederic Ruffy
•
CTXS
,
C
,
BAC
•
Comment!
|
Quick Read
Where the Big Money Is Betting Big
May 15
•
Andrew Mickey
•
ALTH
,
AUY
,
AEM
•
45 Comments
|
Quick Read
Latest Trend Leaders
May 15
•
Trade Radar Operator
•
BVN
,
BWF
,
AZN
•
2 Comments
|
Quick Read
Tuesday's Options Recap
May 12
•
Frederic Ruffy
•
AMD
,
CTRP
,
GERN
•
Comment!
|
Quick Read
Stem Cell Index Surges in Past Week
May 11
•
Mike Havrilla
•
CYTX
,
GERN
,
IBB
•
3 Comments
|
Quick Read
Tuesday's Options Recap
May 5
•
Frederic Ruffy
•
ASTM
,
DRYS
,
ALU
•
1 Comment
|
Quick Read
Pre-Market Report: Stocks on Course for Lower Start
Apr 22
•
MidnightTrader.com
•
FRE
,
F
,
BA
•
2 Comments
|
Quick Read
Reversal of Stem Cell Research Ban: 13 Stocks to Benefit
Mar 12
•
Brian Dean
•
ARIA
,
ALXN
,
ACTC
•
8 Comments
|
Quick Read
Geron: The Excitement is Back
Mar 11
•
Investment U
•
GERN
•
2 Comments
|
Quick Read
Wall Street Breakfast: Must-Know News
Mar 10
•
SA Editor Rachael Granby
•
ASTM
,
BRK.A
,
BCS
•
4 Comments
|
Quick Read
12 Stem Cell Stocks - Updated
Mar 9
•
Stockerblog
•
ARIA
,
ALXN
,
CELG
•
6 Comments
|
Quick Read
Cytori Therapeutics: Natural Play on Cosmetic Medicine
Mar 2
•
Mike Havrilla
•
CYTX
,
GERN
,
GE
•
1 Comment
|
Quick Read
Wall Street Breakfast: Must-Know News
Feb 27
•
SA Editor Rachael Granby
•
AES
,
BID
,
ADSK
•
13 Comments
|
Quick Read
Friday's Options Recap
Feb 13
•
Frederic Ruffy
•
AA
,
GMGMQ.PK
,
GERN
•
1 Comment
|
Quick Read
Thursday's Options Recap
Feb 12
•
Frederic Ruffy
•
BAC
,
ASTM
,
AIPC
•
1 Comment
|
Quick Read
Bullish Thesis for Biotech Remains Intact
Feb 5
•
Michael Becker
•
ALPMF.PK
,
BMRN
,
ANDS
•
1 Comment
|
Quick Read
Geron Opens a New Era for Stem Cell Research
Jan 27
•
Investment U
•
GERN
•
4 Comments
|
Quick Read
Geron Corp: Up 50% on Nothing but Hope
Jan 27
•
Eric Falkenstein
•
GERN
•
18 Comments
|
Quick Read
14 Stem Cell, Renewable Energy Opportunities for the Obama Era
Jan 26
•
Kelvin Schulle
•
CSIQ
,
APWR
,
CCJ
•
17 Comments
|
Quick Read
Trading the Trials and FDA Decision Calendar
Jan 26
•
Mike Havrilla
•
DSKYY.PK
,
ALNY
,
GERN
•
1 Comment
|
Quick Read
Market Claws Its Way Back Friday
Jan 25
•
Bill Cara
•
DIA
,
GERN
,
GE
•
Comment!
|
Quick Read
Was Geron's Announcement Timed?
Jan 25
•
Mike Huckman
•
GERN
•
9 Comments
|
Quick Read
Stem Cell Research Stocks Soar as Obama Takes Office
Jan 25
•
Mike Havrilla
•
GENZ
,
CYTX
,
ASTM
•
5 Comments
|
Quick Read
Wall Street Breakfast: Must-Know News
Jan 23
•
SA Editor Rachael Granby
•
AMD
,
BAC
,
CNI
•
21 Comments
|
Quick Read
Stem Cell and Regenerative Medicine Stocks Surge in December
Dec 20, 2008
•
Mike Havrilla
•
ATSI
,
CYTX
,
ABMD
•
7 Comments
|
Quick Read
Healthcare: Investing Trends for 2009
Dec 19, 2008
•
Mike Havrilla
•
AMSF
,
AET
,
AFL
•
3 Comments
|
Quick Read
ETF Ideas Poised to Benefit from Pending Healthcare Reform
Dec 8, 2008
•
Mike Havrilla
•
ASTM
,
CERN
,
CRY
•
1 Comment
|
Quick Read
Stem Cell Research: The Next Boom?
Nov 22, 2008
•
Andrew Mickey
•
GLW
,
GERN
,
STEM
•
Comment!
|
Quick Read
Regenerative Medicine: Big Pharma's Next Frontier
Nov 19, 2008
•
Mike Havrilla
•
BMTI
,
ASTM
,
CRY
•
2 Comments
|
Quick Read
Recent Russell 3000 Movers
Nov 4, 2008
•
J Clinton Hill
•
AAON
,
ABR
,
ACTU
•
Comment!
|
Quick Read
10 Biotechs in Stem Cells that Could Profit Under the Democrats
Jun 1, 2008
•
Ketan Desai
•
ASTM
,
ATHX
,
BHRT
•
15 Comments
|
Quick Read
Russian Roulette Pays Off for Antigenics
Apr 9, 2008
•
Mike Huckman
•
CEGE
,
AGEN
,
DNDN
•
5 Comments
|
Quick Read
1
2
Next Page